Left ventricular noncompaction in patients with β-thalassemia: Uncovering a previously unrecognized abnormality

American Journal of Hematology

Volumn 87, Issue 12, 2012, Pages 1079-1083

  Piga, Antonio ^a   Longo, Filomena ^a   Musallam, Khaled M ^b   Veltri, Andrea ^c   Ferroni, Francesca ^d   Chiribiri, Amedeo ^c,e   Bonamini, Rodolfo ^d  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SAN LUIGI GONZAGA UNIVERSITY HOSPITAL   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; DEFERASIROX; DEFERIPRONE; DEFEROXAMINE; FERRITIN; HEMOGLOBIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CONGENITAL HEART DISEASE; CROSS-SECTIONAL STUDY; FAMILY HISTORY; FEMALE; FERRITIN BLOOD LEVEL; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFECTION; IRON CHELATION; IRON OVERLOAD; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RIGIDITY; RISK ASSESSMENT; SPLENECTOMY; THALASSEMIA INTERMEDIA; THALASSEMIA MAJOR; TREATMENT DURATION; VENTRICULAR NONCOMPACTION;

ADOLESCENT; ADULT; BETA-THALASSEMIA; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HEART VENTRICLES; HUMANS; IRON OVERLOAD; ISOLATED NONCOMPACTION OF THE VENTRICULAR MYOCARDIUM; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 84869181967     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23323     Document Type: Article

References (43)

1. Weisz SH, Limongelli G, Pacileo G, et al. Left ventricular noncompaction in children. Congenit Heart Dis 2010; 5: 384-397.
2. Gimeno JR, Lacunza J, Garcia-Alberola A, et al. Penetrance and risk profile in inherited cardiac diseases studied in a dedicated screening clinic. Am J Cardiol 2009; 104: 406-410.
3. Belanger A, Miller M, Donthireddi U, et al. New classification scheme of left ventricular noncompaction and correlation with ventricular performance. Am J Cardiol 2008; 102: 92-96.
4. Chin T, Perloff J, Williams R, et al. Isolated noncompaction of left ventricular myocardium. A study of eight cases. Circulation 1990; 82: 507-513.
5. Oechslin E, Attenhofer Jost C, Rojas J, et al. Long-term follow-up of 34 adults with isolated left ventricular noncompaction: A distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol 2000; 36: 493-500.
6. Stöllberger C, Finsterer J. Left ventricular hypertrabeculation/noncompaction. J Am Soc Echocardiogr 2004; 17: 91-100.
7. Burke A, Mont E, Kutys R, et al. Left ventricular noncompaction: A pathological study of 14 cases. Hum Pathol 2005; 36: 403-411.
8. Petersen S, Selvanayagam J, Wiesmann F, et al. Left ventricular non-compaction: Insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol 2005; 46: 101-105.
9. Fazio G, Novo G, D'Angelo L, et al. Magnetic resonance in isolated noncompaction of the ventricular myocardium. Int J Cardiol 2010; 140: 367-369.
10. Sasse-Klaassen S, Gerull B, Oechslin E, et al. Isolated noncompaction of the left ventricular myocardium in the adult is an autosomal dominant disorder in the majority of patients. Am J Med Genet A 2003; 119: 162-167.
11. Hoedemaekers YM, Caliskan K, Michels M, et al. The importance of genetic counseling, DNA diagnostics, and cardiologic family screening in left ventricular noncompaction cardiomyopathy. Circ Cardiovasc Genet 2010; 3: 232-239.
12. Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006; 113: 1807-1816.
13. Finsterer J. Cardiogenetics, neurogenetics, and pathogenetics of left ventricular hypertrabeculation/noncompaction. Pediatr Cardiol 2009; 30: 659-681.
14. Stöllberger C, Finsterer J, Blazek G. Left ventricular hypertrabeculation/noncompaction and association with additional cardiac abnormalities and neuromuscular disorders. Am J Cardiol 2002; 90: 899-902.
15. Scaglia F, Towbin J, Craigen W, et al. Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics 2004; 114: 925-931.
16. Zaragoza M, Arbustini E, Narula J. Noncompaction of the left ventricle: Primary cardiomyopathy with an elusive genetic etiology. Curr Opin Pediatr 2007; 19: 619-627.
17. Monserrat L, Hermida-Prieto M, Fernandez X, et al. Mutation in the α-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects. Eur Heart J 2007; 28: 1953-1961.
18. Battaglia A, Hoyme H, Dallapiccola B, et al. Further delineation of deletion 1p36 syndrome in 60 patients: A recognizable phenotype and common cause of developmental delay and mental retardation. Pediatrics 2008; 121: 404-410.
19. Bhatia NL, Tajik AJ, Wilansky S, et al. Isolated noncompaction of the left ventricular myocardium in adults: A systematic overview. J Card Fail 2011; 17: 771-778.
20. Aras D, Tufekcioglu O, Ergun K, et al. Clinical features of isolated ventricular noncompaction in adults long-term clinical course, echocardiographic properties, and predictors of left ventricular failure. J Card Fail 2006; 12: 726-733.
21. Weiford BC, Subbarao VD, Mulhern KM. Noncompaction of the ventricular myocardium. Circulation 2004; 109: 2965-2971.
22. Pfammatter J, Paul T, Flik J, et al. Q-fever associated myocarditis in a 14-year-old boy. Z Kardiol 1995; 84: 947-950.
23. Bleyl S, Mumford B, Thompson V, et al. Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome. Am J Hum Genet 1997; 61: 868-872.
24. Alter P, Maisch B. Non-compaction cardiomyopathy in an adult with hereditary spherocytosis. Eur J Heart Fail 2007; 9: 98-99.
25. Celebi A, Gulel O, Cicekcioglu H, et al. Isolated noncompaction of the left ventricular myocardium complicated by thromboembolic cerebrovascular accident in a patient with essential thrombocythemia. Int J Cardiol 2008; 128: e22-e24.
26. Luckie M, Irwin B, Nair S, et al. Left ventricular non-compaction in identical twins with thalassaemia and cardiac iron overload. Eur J Echocardiogr 2009; 10: 509-512.
27. New York Heart Association. Criteria Committee, New York Heart Association: Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. Boston: Little, Brown and Company; 1994.
28. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002; 105: 539-542.
29. Kramer C, Barkhausen J, Flamm S, et al. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: Board of trustees task force on standardized protocols. J Cardiovasc Magn Reson 2008; 10: 35.
30. Maceira AM, Prasad SK, Khan M, et al. Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2006; 8: 417-426.
31. Westwood M, Anderson LJ, Firmin DN, et al. A single breath-hold multiecho T2*cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging 2003; 18: 33-39.
32. Wood JC. Magnetic resonance imaging measurement of iron overload. Curr Opin Hematol 2007; 14: 183-190.
33. Brittenham GM, Farrell DE, Harris JW, et al. Magnetic-susceptibility measurement of human iron stores. N Engl J Med 1982; 307: 1671-1675.
34. Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128: 343-350.
35. Murphy RT, Thaman R, Blanes JG, et al. Natural history and familial characteristics of isolated left ventricular non-compaction. Eur Heart J 2005; 26: 187-192.
36. Stollberger C, Finsterer J. Left ventricular hypertrabeculation/noncompaction. J Am Soc Echocardiogr 2004; 17: 91-100.
37. El-Beshlawy A, Youssry I, El-Saidi S, et al. Pulmonary hypertension in β-thalassemia major and the role of L-carnitine therapy. Pediatr Hematol Oncol 2008; 25: 734-743.
38. Wood JC. Cardiac iron across different transfusion-dependent diseases. Blood Rev 2008; 22 (Suppl 2): S14-S21.
39. Chun CZ, Tsai HJ, Chen TT. Trout Ea4- or human Eb-peptide of pro-IGF-I disrupts heart, red blood cell, and vasculature development in zebrafish embryos. Mol Reprod Dev 2006; 73: 1112-1121.
40. Kawel N, Nacif M, Arai AE, et al. Trabeculated (noncompacted) and compact myocardium in adults: The multi-ethnic study of atherosclerosis. Circ Cardiovasc Imaging 2012; 5: 357-366.
41. Kremastinos DT, Farmakis D. Iron overload cardiomyopathy in clinical practice. Circulation 2011; 124: 2253-2263.
42. Borgna-Pignatti C. Surviving with thalassemia major: The Italian experience. Pediatr Hematol Oncol 2007; 24: 75-78.
43. Kirk P, Roughton M, Porter JB, et al. Cardiac T2*magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation 2009; 120: 1961-1968.